Clinical trials: COVID19 Patients
COVID-19
The RAPID COVID-19 TRIAGE Algorithm
This study is being conducted to study the use and application of a point-of-care (POC) Covid-19 test developed by Spartan BioSciences and recently approved for clinical use by Health Canada.
- Trial name
- NCT04353154
- Testing
- Spartan Cube Point-of Care Covid-19 test
- Where
- Canada
- Volunteers
- 66 people
- Sponsor
- Ottawa Heart Institute Research Corporation
Covid19
Study in COvid-19 Patients With iveRmectin (CORVETTE-01)
Treatment of mild COVID-19 is basically performed at an outpatient clinic, then when the symptom and clinical findings exacerbate to a moderate level, patients are admitted. There is no standard treatment for mild cases.
- Trial name
- NCT04703205
- Testing
- Ivermectin 3 MG
- Where
- Japan
- Volunteers
- 214 people, healthy volunteers welcome
- Sponsor
- Kitasato University
No-Show Patients, Therapeutic Adherence and Compliance
Evaluation of the Relationship Between Missed Appointments and Adherence to Medical Indications
We will conduct a cross-sectional study involving adults with type 2 diabetes mellitus. Our primary objective is to evaluate the association between nonattendance and participants' adherence to both pharmacological and…
- Conditions
- No-Show Patients, Therapeutic Adherence and Compliance, Type 2 Diabetes Mellitus, COVID-19
- Trial name
- NCT06501456
- Where
- Argentina
- Volunteers
- 46 people
- Sponsor
- Hospital Italiano de Buenos Aires
COVID19
Effectiveness of Hydroxychloroquine in Covid-19 Patients
To find the effectiveness of hydroxychloroquine alone and adjuvant with azithromycin in mild to severe Covide-19 pneumonia patients admitted to Coronavirus cell/ward of Ayub Teaching hospital, Abbottabad Pakistan.
- Trial name
- Covid (NCT04328272)
- Testing
- Hydroxychloroquine 200 Mg Oral Tablet, Azithromycin 500Mg Oral Tablet, Glucose tablets
- Where
- Pakistan
- Volunteers
- 75 people
- Sponsor
- Prof. Dr. Umar Farooq
Healthy, Health Care Worker Patient Transmission
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19
The purpose of this research study is to look at high dose zinc versus multivitamin micronutrient supplementation to support immune health in the setting of the COVID-19 pandemic.
- Conditions
- Healthy, Health Care Worker Patient Transmission, Aging
- Trial name
- ZnCOVID-19 (NCT04551339)
- Testing
- PreserVision AREDS formulation soft gels or tablets, Multivitamin with 11mg of zinc
- Where
- 3 sites in United States
- Volunteers
- 2,700 people, healthy volunteers welcome
- Sponsor
- Mayo Clinic
COVID-19, Coronavirus
Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning
The purpose of this study was to assess the performance of a machine learning algorithm which identifies patients for whom hydroxychloroquine treatment is associated with predicted survival.
- Conditions
- COVID-19, Coronavirus, Mortality
- Trial name
- IDENTIFY (NCT04423991)
- Testing
- COViage
- Where
- United States
- Volunteers
- 290 people
- Sponsor
- Dascena
Covid-19
A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients
Pakistan is a resource restraint country, it's not possible to carry out coronavirus testing at mass scale. Simple cost effective intervention against the present pandemic is highly desirable.
- Trial name
- GARGLES (NCT04341688)
- Testing
- Gargle/Mouthwash
- Volunteers
- 50 people
- Sponsor
- Aga Khan University
COVID-19
Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection
Background: In December 2019, patients with pneumonia secondary to a new subtype of Coronavirus (COVID-19) were identified in China. In a few weeks the virus spread and cases started practically all over the world.
- Trial name
- NCT04391127
- Testing
- Hydroxychloroquine, Ivermectin
- Where
- Mexico
- Volunteers
- 108 people
- Sponsor
- Centenario Hospital Miguel Hidalgo
SARS-CoV Infection
Oral Manifestation in Patients With SARS-CoV2 Infection.
The oral cavity is particularly susceptible to viral infection with several viruses such as herpes simplex virus, cytomegalovirus and Zika virus because of its structures, especially salivary glands and soft tissues Moreover…
- Trial name
- NCT04821986
- Where
- Egypt
- Volunteers
- 583 people
- Sponsor
- Fayoum University
COVID-19
Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Moderate COVID19.
To evaluate the efficacy of subcutaneous ropeginterferon alfa 2b ( P1101combined with standard of care (SOC) compared with standard care alone in hospitalized adults with moderate COVID 19.
- Trial name
- NCT05770466
- Testing
- P1101 (Ropeginterferon alfa-2b), SOC
- Where
- Taiwan
- Volunteers
- 134 people
- Sponsor
- National Taiwan University Hospital
Acute Kidney Injury, Covid19
CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19
Since the emergence of the new strain of betacoronavirus (SARS-CoV-2) and its important clinical repercussions, it has been described that patients with its associated pneumonia (COVID-19) have high rates of thrombotic events…
- Trial name
- NCT04487990
- Testing
- unfractionated Heparin
- Where
- Brazil
- Volunteers
- 118 people
- Sponsor
- University of Sao Paulo General Hospital
IMMUNOTHERAPY
Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients
Out of 49 early-stage critically-ill COVID-19 patients, 21 patients are the experimental group who take convalescent plasma compared to 28 patients receive only conventional therapy without taking Convalescent plasma.
- Trial name
- NCT04441424
- Testing
- Convalescent plasma, Hydroxychloroquin with Azithromycin
- Where
- Iraq
- Volunteers
- 49 people
- Sponsor
- Alkarkh Health Directorate-Baghdad
Long COVID-19 Syndrome
Digital Physiotherapy Practice in Long Covid-19 Patients
The COVID-19 can cause important sequels in the respiratory system by bilateral pneumonia and frequently presents loss of strength, dyspnea, polyneuropathies and multi-organic affectation.
- Trial name
- TRCovidA (NCT04742946)
- Testing
- Digital Physiotherapy Practice (Telerehabilitation)
- Where
- Spain
- Volunteers
- 27 people, healthy volunteers welcome
- Sponsor
- Universidad de Granada
COVID-19
mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms
TACTIC-E is a randomised, parallel arm, open-label platform trial for investigating potential treatments for COVID-19 disease. While SARS-CoV infection evades detection by the immune system in the first 24 hours of infection, it…
- Trial name
- NCT04393246
- Testing
- EDP1815, Dapagliflozin, Ambrisentan
- Where
- United Kingdom
- Volunteers
- 454 people
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
Covid19
Surgical Face Mask Effects in Patients With COVID-19
The use of personal protective equipment is mandatory for healthcare workers caring patient with COVID-19. To maximise the reduction of virus spread during clinical procedures involving the presence of healthcare workers, it is…
- Trial name
- NCT04689542
- Testing
- Sit-To-Stand test
- Where
- Belgium
- Volunteers
- 28 people
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
COVID-19 Patients
Investigating Long-term Health Effects and Complications in COVID-19 Recoveries
Clarify the incidence of functional impairments in cured COVID-19 patients and identify influencing factors. Build a multi-omics database for COVID-19 patients in the recovery period to elucidate the biological biomarkers and…
- Trial name
- NCT06349720
- Testing
- respiratory rehabilitation
- Where
- China
- Volunteers
- 17,000 people, healthy volunteers welcome
- Sponsor
- Zhaohui Tong
Cancer, COVID
Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19
Evaluation of the ddPCR ability to detect the SARS-CoV-2 in nasopharyngeal samples of symptomatic patients with suspected COVID-19 infection using an IgG serological assay (EUROIMMUN Anti-SARS-Cov2 ELISA Ig) as gold/reference…
- Trial name
- ONCOVID-21 (NCT04510454)
- Testing
- Nasopharyngeal and throat/oropharyngeal swabs analyses by RT-PCR and ddPCR
- Where
- France
- Volunteers
- 100 people
- Sponsor
- Centre Leon Berard
SARS-COV2 Infection, COVID-19 Disease
COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
Effect of Covid-19 disease in clotting factors levels in hospitalized patients
- Conditions
- SARS-COV2 Infection, COVID-19 Disease, Hospitalized Patients
- Trial name
- NCT04787510
- Testing
- low molecular weight Heparin as standard of care treatment
- Where
- Greece
- Volunteers
- 50 people
- Sponsor
- University Hospital, Ioannina
COVID-19
Clinical and Biological Predictors of COVID-19 Disease in Older Patients
The project is an observational, prospective study. Its aim is to deepen our understanding of COVID-19 in older patients hospitalized and diagnosed with COVID-19.
- Trial name
- NCT04348396
- Where
- 3 sites in Italy
- Volunteers
- 300 people
- Sponsor
- Istituto Nazionale di Ricovero e Cura per Anziani
COVID
Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
GC004 is a Phase I trial to evaluate the safety and the immune responses of a therapeutic vaccine in SARS-CoV-2 infected patients.
- Trial name
- NCT04428073
- Testing
- Covax-19™
- Volunteers
- 32 people
- Sponsor
- GeneCure Biotechnologies
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.